The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 268 participants.

Also called NCT01580553

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 268 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01580553
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01580553. Randomized; double masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2012-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure
Condition
Heart Failure,
Intervention (Drug)
Levocarnitine Injection
Intervention (Drug)
Levocarnitine placebo
Lead sponsor
Lee's Pharmaceutical Limited (class: industry)

Record details

Record id
cardio:ct-nct01580553
Content hash
45613ddb6dece8def70e8800798ac0742a82b28e449f84feedb1aedf9c418469